Mary Philip

8.6k total citations · 4 hit papers
64 papers, 4.9k citations indexed

About

Mary Philip is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Mary Philip has authored 64 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 22 papers in Immunology and 19 papers in Pathology and Forensic Medicine. Recurrent topics in Mary Philip's work include Immune Cell Function and Interaction (16 papers), Lymphoma Diagnosis and Treatment (16 papers) and Infective Endocarditis Diagnosis and Management (14 papers). Mary Philip is often cited by papers focused on Immune Cell Function and Interaction (16 papers), Lymphoma Diagnosis and Treatment (16 papers) and Infective Endocarditis Diagnosis and Management (14 papers). Mary Philip collaborates with scholars based in United States, France and Italy. Mary Philip's co-authors include Andrea Schietinger, Hans Schreiber, Donald A. Rowley, Peter Lauer, Anjana Rao, W. Nicholas Haining, Nicholas P. Restifo, Christian U. Blank, Axel Kallies and Pamela L. Schwartzberg and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Mary Philip

60 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Defining ‘T cell exhaustion’

2019 953 citations Mary Philip, Andrea Schietinger et al. Nature reviews. Immunology profile →
Chromatin states define tumour-specific T cell dysfunction and reprogramming

2017 605 citations Mary Philip, Andrea Schietinger et al. profile →
CD8+ T cell differentiation and dysfunction in cancer

2021 590 citations Mary Philip, Andrea Schietinger Nature reviews. Immunology profile →
Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis

2016 484 citations Andrea Schietinger, Mary Philip et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary Philip United States	22	3.0k	2.7k	1.2k	447	352	64	4.9k
Matthew D. Vesely United States	18	2.6k 0.9×	2.4k 0.9×	936 0.8×	400 0.9×	179 0.5×	52	4.1k
Eddy C. Hsueh United States	41	2.5k 0.8×	3.0k 1.1×	1.6k 1.3×	674 1.5×	253 0.7×	95	5.1k
Hagen Kulbe Germany	27	2.6k 0.9×	2.1k 0.8×	1.3k 1.1×	834 1.9×	209 0.6×	67	4.4k
Andrea Schietinger United States	25	3.5k 1.2×	3.1k 1.1×	1.2k 1.0×	336 0.8×	127 0.4×	41	5.1k
Yulia Nefedova United States	29	3.9k 1.3×	2.2k 0.8×	1.9k 1.6×	557 1.2×	158 0.4×	53	5.7k
Lindy G. Durrant United Kingdom	40	2.7k 0.9×	2.0k 0.7×	1.9k 1.5×	338 0.8×	246 0.7×	157	4.7k
Marco Donia Denmark	45	3.8k 1.3×	4.3k 1.6×	2.0k 1.6×	490 1.1×	223 0.6×	195	6.7k
David Avigan United States	42	3.7k 1.3×	2.9k 1.1×	3.0k 2.5×	702 1.6×	329 0.9×	208	7.5k
Giuseppe Masucci Sweden	40	3.2k 1.1×	2.5k 0.9×	908 0.7×	298 0.7×	351 1.0×	125	4.8k
Yanyan Lou United States	33	2.5k 0.9×	3.2k 1.2×	1.4k 1.2×	578 1.3×	211 0.6×	122	5.3k

Countries citing papers authored by Mary Philip

Since Specialization

Citations

This map shows the geographic impact of Mary Philip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Philip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Philip more than expected).

Fields of papers citing papers by Mary Philip

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Philip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Philip. The network helps show where Mary Philip may publish in the future.

Co-authorship network of co-authors of Mary Philip

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Philip. A scholar is included among the top collaborators of Mary Philip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Philip. Mary Philip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Revetta, Frank, et al.. (2024). Vaccination generates functional progenitor tumor-specific CD8 T cells and long-term tumor control. Journal for ImmunoTherapy of Cancer. 12(10). e009129–e009129.

Philip, Mary, Jérôme Hourdain, Noémie Resseguier, et al.. (2024). Atrioventricular conduction disorders in aortic valve infective endocarditis. Archives of cardiovascular diseases. 117(5). 304–312. 1 indexed citations

Murray, Kristen A., et al.. (2023). Tumor-Reactive CD8+ T Cells Enter a TCF1+PD-1− Dysfunctional State. Cancer Immunology Research. 11(12). 1630–1641. 7 indexed citations

Zumbo, Paul, et al.. (2023). Hallmarks of CD8+ T cell dysfunction are established within hours of tumor antigen encounter before cell division. Nature Immunology. 24(9). 1527–1539. 64 indexed citations

Arregle, Florent, Christophe Tribouilloy, Bernard Cosyns, et al.. (2023). Multimodality imaging in marantic endocarditis associated with cancer: a multicentric cohort study. European Heart Journal - Cardiovascular Imaging. 24(12). 1620–1626. 5 indexed citations

Bohbot, Yohann, Rossella Maria Benvenga, Mary Philip, et al.. (2023). Characteristics and prognosis of isolated aortic valve infective endocarditis in patients with bicuspid aortic valves: a propensity matched study. Frontiers in Cardiovascular Medicine. 10. 1304957–1304957. 2 indexed citations

Arregle, Florent, Roch Giorgi, Mary Philip, et al.. (2022). Influence of the healthcare pathway on the outcome of patients with infective endocarditis. European Heart Journal Acute Cardiovascular Care. 11(9). 672–681. 3 indexed citations

Philip, Mary, Julien Mancini, L. Tessonnier, et al.. (2021). 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the diagnosis of native valve infective endocarditis: A prospective study. Archives of cardiovascular diseases. 114(3). 211–220. 11 indexed citations

Philip, Mary & Andrea Schietinger. (2021). CD8+ T cell differentiation and dysfunction in cancer. Nature reviews. Immunology. 22(4). 209–223. 590 indexed citations breakdown →

10.

Lynch, Ryan C., Ryan D. Cassaday, Stephen D. Smith, et al.. (2021). Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study. The Lancet Haematology. 8(8). e562–e571. 33 indexed citations

11.

Bohbot, Yohann, Fanny Peugnet, Andreina Carbone, et al.. (2020). Characteristics and Prognosis of Patients With Left-Sided Native Bivalvular Infective Endocarditis. Canadian Journal of Cardiology. 37(2). 292–299. 14 indexed citations

12.

Carbone, Andreina, Basile Mouhat, Mary Philip, et al.. (2020). Spondylitis: A frequent and severe complication of infective endocarditis. Archives of Cardiovascular Diseases Supplements. 12(1). 82–82.

13.

Li, Zhuoyan, Mary Philip, & P. Brent Ferrell. (2020). Alterations of T-cell-mediated immunity in acute myeloid leukemia. Oncogene. 39(18). 3611–3619. 41 indexed citations

14.

Oyebanji, Oyetola O., et al.. (2018). Utility of Nanomedicine for Cancer Treatment. Journal of Nanomedicine & Nanotechnology. 9(1). 6 indexed citations

15.

Philip, Mary, et al.. (2018). A ten year study of pediatric leprosy cases in a tertiary care centre in south Kerala.. 90(2). 95–99. 2 indexed citations

16.

Cassaday, Ryan D., Jonathan R. Fromm, Andrew J. Cowan, et al.. (2017). Radiographic and High-Throughput Sequencing (HTS)-Based Response Assessment after Brentuximab Vedotin (BV) Plus Ifosfamide, Carboplatin, and Etoposide (ICE) for Relapsed/Refractory (Rel/Ref) Classical Hodgkin Lymphoma (cHL): Updated Results of a Phase I/II Trial. Blood. 130. 2806–2806. 9 indexed citations

17.

Graf, Solomon A., Philip A. Stevenson, Leona Holmberg, et al.. (2015). Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma. Annals of Oncology. 26(11). 2323–2328. 20 indexed citations

18.

Onishi, Maika, Leona Holmberg, Andrei R. Shustov, et al.. (2013). Brentuximab Vedotin Administered To Platinum-Refractory Transplant Naïve Hodgkin Lymphoma Patients Can Increase The Proportion Achieving FDG-PET Negative Status. Blood. 122(21). 2106–2106. 2 indexed citations

19.

Schietinger, Andrea, Mary Philip, Barbara A. Yoshida, et al.. (2006). A Mutant Chaperone Converts a Wild-Type Protein into a Tumor-Specific Antigen. Science. 314(5797). 304–308. 125 indexed citations

20.

Wu, Terry, Zhihai Qin, Thomas Blankenstein, et al.. (2004). Long-Term Suppression of Tumor Growth by TNF Requires a Stat1- and IFN Regulatory Factor 1-Dependent IFN-γ Pathway but Not IL-12 or IL-18. The Journal of Immunology. 172(5). 3243–3251. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact